AKT1 and brain neoplasm: In human glioblastoma, blocking of TRIM21/Ro52 activity due to protein kinase B (AKT) activation impairs the proteasomal degradation of phosphofructokinase-1 (PFK1), the rate-limiting glycolysis enzyme, resulting in the promotion of glycolysis and brain tumor proliferation [108].